Syngene shareholders approve Kiran Mazumdar-Shaw as Executive Chairperson

Management Changes View source PDF Explain this filing

SYNGENE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹441.80

prior close

₹442.70

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.8%-0.3% vs market

Healthcare Research Analytics & Technology peers, median of 5sector-0.4%+0.9% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Smallcap 250 and 0.9 pts more than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

+1.2

15m

+1.1

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5+0.8-0.3-0.4+0.9

Next day

-1.3+0.2-1.5-1.7+0.4

+0.3+0.4-0.1-2.7+2.9

-1.0-0.1-0.9-1.7+0.7

-1.8-0.5-1.3-3.2+1.5

-0.3+0.0-0.3+2.6-2.9

-0.4+1.5-1.9+2.9-3.3

15d

-5.2+1.5-6.6-3.3-1.9

-8.0+0.8-8.8+2.0-10.0

-9.9+3.7-13.7+8.4-18.3

-14.4+3.1-17.5+10.9-25.4

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syngene International shareholders approved (91.40% in favor) the change in role of Ms. Kiran Mazumdar-Shaw from Non-Executive Chairperson to Executive Chairperson and Key Managerial Personnel, along with managerial remuneration. Promoters voted 100% in favor; public institutions showed 21.57% dissent. Postal ballot voting closed June 19, 2026.

Likely market impact

Founder Kiran Mazumdar-Shaw moves to executive leadership with pay, signalling deeper promoter involvement in day-to-day operations.